ID   K1C13_HUMAN             Reviewed;         458 AA.
AC   P13646; Q53G54; Q6AZK5; Q8N240;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 4.
DT   28-JUN-2023, entry version 221.
DE   RecName: Full=Keratin, type I cytoskeletal 13;
DE   AltName: Full=Cytokeratin-13;
DE            Short=CK-13;
DE   AltName: Full=Keratin-13;
DE            Short=K13;
GN   Name=KRT13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS VAL-187 AND ALA-298.
RX   PubMed=2475110; DOI=10.1016/0006-291x(89)90847-4;
RA   Schulz P., Wachter E., Hochstrasser K., Wild A.G., Mischke D.;
RT   "Sequence of a human keratin 13 specific cDNA encompassing coil 1B through
RT   the 3' end.";
RL   Biochem. Biophys. Res. Commun. 162:1522-1527(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SEQUENCE REVISION, PROTEIN SEQUENCE
RP   OF 291-299, AND VARIANTS VAL-187 AND ALA-298.
RX   PubMed=2477803; DOI=10.1093/nar/17.19.7984;
RA   Mischke D., Schulz P., Wild A.G.;
RT   "The N-, but not the C-terminal domains of human keratins 13 and 15 are
RT   closely related.";
RL   Nucleic Acids Res. 17:7984-7984(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND VARIANTS
RP   VAL-187 AND ALA-298.
RX   PubMed=2483837; DOI=10.1111/j.1432-0436.1989.tb00612.x;
RA   Kuruc N., Leube R.E., Moll I., Bader B.L., Franke W.W.;
RT   "Synthesis of cytokeratin 13, a component characteristic of internal
RT   stratified epithelia, is not induced in human epidermal tumors.";
RL   Differentiation 42:111-123(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 3), AND VARIANTS VAL-187 AND
RP   ALA-298.
RX   PubMed=9714826; DOI=10.1016/s0378-1119(98)00297-2;
RA   Waseem A., Alam Y., Dogan B., White K.N., Leigh I.M., Waseem N.H.;
RT   "Isolation, sequence and expression of the gene encoding human keratin
RT   13.";
RL   Gene 215:269-279(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS VAL-187
RP   AND ALA-298.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS VAL-187
RP   AND ALA-298.
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS VAL-187
RP   AND ALA-298.
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 124-135; 176-222; 291-318 AND 416-429, PHOSPHORYLATION
RP   AT SER-427, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., von Kriegsheim A.F., Kolch W.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [10]
RP   GLYCOSYLATION.
RX   PubMed=2474541; DOI=10.1016/s0021-9258(18)71636-0;
RA   King I.A., Hounsell E.F.;
RT   "Cytokeratin 13 contains O-glycosidically linked N-acetylglucosamine
RT   residues.";
RL   J. Biol. Chem. 264:14022-14028(1989).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-27 AND ARG-35, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   VARIANT WSN2 PRO-119.
RX   PubMed=7493031; DOI=10.1038/ng1295-453;
RA   Richard G., de Laurenzi V., Didona B., Bale S.J., Compton J.G.;
RT   "Keratin 13 point mutation underlies the hereditary mucosal epithelial
RT   disorder white sponge nevus.";
RL   Nat. Genet. 11:453-455(1995).
RN   [19]
RP   VARIANTS WSN2 THR-108 AND PRO-115.
RX   PubMed=10561721; DOI=10.1111/j.1601-0825.1999.tb00097.x;
RA   Rugg E.L., Magee G., Wilson N., Brandrup F., Hamburger J., Lane E.B.;
RT   "Identification of two novel mutations in keratin 13 as the cause of white
RT   sponge naevus.";
RL   Oral Dis. 5:321-324(1999).
RN   [20]
RP   VARIANT WSN2 SER-112.
RX   PubMed=11379896; DOI=10.1177/00220345010800031401;
RA   Terrinoni A., Rugg E.L., Lane E.B., Melino G., Felix D.H., Munro C.S.,
RA   McLean W.H.I.;
RT   "A novel mutation in the keratin 13 gene causing oral white sponge nevus.";
RL   J. Dent. Res. 80:919-923(2001).
RN   [21]
RP   VARIANT WSN2 PRO-111.
RX   PubMed=14600690; DOI=10.1016/s1079-2104(03)00372-x;
RA   Shibuya Y., Zhang J., Yokoo S., Umeda M., Komori T.;
RT   "Constitutional mutation of keratin 13 gene in familial white sponge
RT   nevus.";
RL   Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96:561-565(2003).
RN   [22]
RP   VARIANT WSN2 HIS-114.
RX   PubMed=18616775; DOI=10.1111/j.1365-2133.2008.08716.x;
RA   Nishizawa A., Nakajima R., Nakano H., Sawamura D., Takayama K., Satoh T.,
RA   Yokozeki H.;
RT   "A de novo missense mutation in the keratin 13 gene in oral white sponge
RT   naevus.";
RL   Br. J. Dermatol. 159:974-975(2008).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-187, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   VARIANTS WSN2 PRO-111 AND CYS-114.
RX   PubMed=25606422; DOI=10.1016/j.mgene.2014.04.008;
RA   Cai W., Chen Z., Jiang B., Yu F., Xu P., Wang M., Wan R., Liu J., Xue Z.,
RA   Yang J., Liu S., Wang X.;
RT   "Keratin 13 mutations associated with oral white sponge nevus in two
RT   Chinese families.";
RL   Meta Gene 2:374-383(2014).
RN   [25]
RP   VARIANT WSN2 ASP-118.
RX   PubMed=29476668; DOI=10.4317/medoral.21437;
RA   Kuerklue E., Oeztuerk S., Cassidy A.J., Ak G., Koray M., Cefle K.,
RA   Palanduez S., Guellueoglu M.G., Tanyeri H., McLean W.H.;
RT   "Clinical features and molecular genetic analysis in a Turkish family with
RT   oral white sponge nevus.";
RL   Med. Oral Patol. Oral Cir. Bucal. 23:e144-e150(2018).
CC   -!- FUNCTION: Type 1 keratin (Probable). Maintains postnatal tongue mucosal
CC       cell homeostasis and tissue organization in response to mechanical
CC       stress, potentially via regulation of the G1/S phase cyclins CCNE1 and
CC       CCNE2 (By similarity). {ECO:0000250|UniProtKB:P08730, ECO:0000305}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC       {ECO:0000305}.
CC   -!- INTERACTION:
CC       P13646; P17661: DES; NbExp=3; IntAct=EBI-1223876, EBI-1055572;
CC       P13646; P14136: GFAP; NbExp=6; IntAct=EBI-1223876, EBI-744302;
CC       P13646; Q8IVS8: GLYCTK; NbExp=3; IntAct=EBI-1223876, EBI-748515;
CC       P13646; A0A024R8L2: hCG_1987119; NbExp=3; IntAct=EBI-1223876, EBI-14103818;
CC       P13646; A0A0S2Z4Q4: HGS; NbExp=3; IntAct=EBI-1223876, EBI-16429135;
CC       P13646; O14964: HGS; NbExp=6; IntAct=EBI-1223876, EBI-740220;
CC       P13646; Q86VS8: HOOK3; NbExp=3; IntAct=EBI-1223876, EBI-1777078;
CC       P13646; P04264: KRT1; NbExp=3; IntAct=EBI-1223876, EBI-298429;
CC       P13646; P35908: KRT2; NbExp=5; IntAct=EBI-1223876, EBI-1247312;
CC       P13646; P19013: KRT4; NbExp=4; IntAct=EBI-1223876, EBI-2371606;
CC       P13646; P02538: KRT6A; NbExp=8; IntAct=EBI-1223876, EBI-702198;
CC       P13646; P04259: KRT6B; NbExp=3; IntAct=EBI-1223876, EBI-740907;
CC       P13646; Q14CN4: KRT72; NbExp=3; IntAct=EBI-1223876, EBI-1221280;
CC       P13646; Q7RTS7: KRT74; NbExp=3; IntAct=EBI-1223876, EBI-968660;
CC       P13646; O95678: KRT75; NbExp=3; IntAct=EBI-1223876, EBI-2949715;
CC       P13646; P07196: NEFL; NbExp=3; IntAct=EBI-1223876, EBI-475646;
CC       P13646; P25786: PSMA1; NbExp=3; IntAct=EBI-1223876, EBI-359352;
CC       P13646; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-1223876, EBI-742688;
CC       P13646; Q8N3L3: TXLNB; NbExp=3; IntAct=EBI-1223876, EBI-6116822;
CC       P13646; A0A0S2Z5X4: ZNF688; NbExp=3; IntAct=EBI-1223876, EBI-16429014;
CC       P13646; PRO_0000449633 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-1223876, EBI-25492395;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A;
CC         IsoId=P13646-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13646-2; Sequence=VSP_016376, VSP_016377;
CC       Name=3;
CC         IsoId=P13646-3; Sequence=VSP_038433;
CC   -!- TISSUE SPECIFICITY: Expressed in some epidermal sweat gland ducts (at
CC       protein level) and in exocervix, esophagus and placenta.
CC       {ECO:0000269|PubMed:2483837}.
CC   -!- PTM: O-glycosylated; glycans consist of single N-acetylglucosamine
CC       residues. {ECO:0000269|PubMed:2474541}.
CC   -!- DISEASE: White sponge nevus 2 (WSN2) [MIM:615785]: A rare disorder
CC       characterized by the presence of soft, white, and spongy plaques in the
CC       oral mucosa. The characteristic histopathologic features are epithelial
CC       thickening, parakeratosis, and vacuolization of the suprabasal layer of
CC       oral epithelial keratinocytes. Less frequently the mucous membranes of
CC       the nose, esophagus, genitalia and rectum are involved.
CC       {ECO:0000269|PubMed:10561721, ECO:0000269|PubMed:11379896,
CC       ECO:0000269|PubMed:14600690, ECO:0000269|PubMed:18616775,
CC       ECO:0000269|PubMed:25606422, ECO:0000269|PubMed:29476668,
CC       ECO:0000269|PubMed:7493031}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Keratin-13 entry;
CC       URL="https://en.wikipedia.org/wiki/Keratin_13";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14640; CAA32786.1; -; mRNA.
DR   EMBL; X52426; CAA36673.1; -; mRNA.
DR   EMBL; AF049259; AAC35754.1; -; Genomic_DNA.
DR   EMBL; AK092276; BAC03847.1; -; mRNA.
DR   EMBL; AK223051; BAD96771.1; -; mRNA.
DR   EMBL; AK223077; BAD96797.1; -; mRNA.
DR   EMBL; AC019349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002661; AAH02661.3; -; mRNA.
DR   EMBL; BC077718; AAH77718.2; -; mRNA.
DR   CCDS; CCDS11396.1; -. [P13646-1]
DR   CCDS; CCDS11397.1; -. [P13646-3]
DR   PIR; A37343; A37343.
DR   PIR; S06088; KRHU3.
DR   RefSeq; NP_002265.2; NM_002274.3. [P13646-3]
DR   RefSeq; NP_705694.2; NM_153490.2. [P13646-1]
DR   AlphaFoldDB; P13646; -.
DR   SMR; P13646; -.
DR   BioGRID; 110058; 95.
DR   IntAct; P13646; 54.
DR   MINT; P13646; -.
DR   STRING; 9606.ENSP00000246635; -.
DR   GlyConnect; 311; 1 O-GlcNAc glycan.
DR   GlyCosmos; P13646; No site information, 1 glycan.
DR   GlyGen; P13646; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P13646; -.
DR   PhosphoSitePlus; P13646; -.
DR   SwissPalm; P13646; -.
DR   BioMuta; KRT13; -.
DR   DMDM; 269849755; -.
DR   jPOST; P13646; -.
DR   MassIVE; P13646; -.
DR   PaxDb; P13646; -.
DR   PeptideAtlas; P13646; -.
DR   PRIDE; P13646; -.
DR   ProteomicsDB; 52951; -. [P13646-1]
DR   ProteomicsDB; 52952; -. [P13646-2]
DR   ProteomicsDB; 52953; -. [P13646-3]
DR   Antibodypedia; 3599; 646 antibodies from 43 providers.
DR   DNASU; 3860; -.
DR   Ensembl; ENST00000246635.8; ENSP00000246635.3; ENSG00000171401.15. [P13646-1]
DR   Ensembl; ENST00000336861.7; ENSP00000336604.3; ENSG00000171401.15. [P13646-3]
DR   GeneID; 3860; -.
DR   KEGG; hsa:3860; -.
DR   MANE-Select; ENST00000246635.8; ENSP00000246635.3; NM_153490.3; NP_705694.3.
DR   UCSC; uc002hwu.2; human. [P13646-1]
DR   AGR; HGNC:6415; -.
DR   CTD; 3860; -.
DR   DisGeNET; 3860; -.
DR   GeneCards; KRT13; -.
DR   HGNC; HGNC:6415; KRT13.
DR   HPA; ENSG00000171401; Tissue enhanced (esophagus, vagina).
DR   MalaCards; KRT13; -.
DR   MIM; 148065; gene.
DR   MIM; 615785; phenotype.
DR   neXtProt; NX_P13646; -.
DR   OpenTargets; ENSG00000171401; -.
DR   Orphanet; 171723; White sponge nevus.
DR   PharmGKB; PA30202; -.
DR   VEuPathDB; HostDB:ENSG00000171401; -.
DR   eggNOG; ENOG502QTM6; Eukaryota.
DR   GeneTree; ENSGT00950000183311; -.
DR   HOGENOM; CLU_012560_8_1_1; -.
DR   InParanoid; P13646; -.
DR   OMA; DAKMTGF; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; P13646; -.
DR   TreeFam; TF332742; -.
DR   PathwayCommons; P13646; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   SignaLink; P13646; -.
DR   BioGRID-ORCS; 3860; 13 hits in 1147 CRISPR screens.
DR   ChiTaRS; KRT13; human.
DR   GeneWiki; Keratin_13; -.
DR   GenomeRNAi; 3860; -.
DR   Pharos; P13646; Tbio.
DR   PRO; PR:P13646; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P13646; protein.
DR   Bgee; ENSG00000171401; Expressed in lower esophagus mucosa and 112 other tissues.
DR   ExpressionAtlas; P13646; baseline and differential.
DR   Genevisible; P13646; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0045095; C:keratin filament; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0007010; P:cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0043555; P:regulation of translation in response to stress; ISS:UniProtKB.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF121; KERATIN, TYPE I CYTOSKELETAL 13; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Direct protein sequencing;
KW   Disease variant; Glycoprotein; Intermediate filament; Keratin; Methylation;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..458
FT                   /note="Keratin, type I cytoskeletal 13"
FT                   /id="PRO_0000063647"
FT   DOMAIN          104..416
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..103
FT                   /note="Head"
FT   REGION          104..139
FT                   /note="Coil 1A"
FT   REGION          140..158
FT                   /note="Linker 1"
FT   REGION          159..250
FT                   /note="Coil 1B"
FT   REGION          251..273
FT                   /note="Linker 12"
FT   REGION          274..412
FT                   /note="Coil 2"
FT   REGION          413..458
FT                   /note="Tail"
FT   REGION          420..458
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        423..451
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         27
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         35
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         62..73
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016376"
FT   VAR_SEQ         351..458
FT                   /note="ETECRYALQLQQIQGLISSIEAQLSELRSEMECQNQEYKMLLDIKTRLEQEI
FT                   ATYRSLLEGQDAKMIGFPSSAGSVSPRSTSVTTTSSASVTTTSNASGRRTSDVRRP ->
FT                   DPGTHQQHRGPAERAPQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_016377"
FT   VAR_SEQ         416..458
FT                   /note="MIGFPSSAGSVSPRSTSVTTTSSASVTTTSNASGRRTSDVRRP -> KRQPP
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:2483837"
FT                   /id="VSP_038433"
FT   VARIANT         81
FT                   /note="F -> Y (in dbSNP:rs12150581)"
FT                   /id="VAR_059376"
FT   VARIANT         108
FT                   /note="M -> T (in WSN2; dbSNP:rs60364670)"
FT                   /evidence="ECO:0000269|PubMed:10561721"
FT                   /id="VAR_016035"
FT   VARIANT         111
FT                   /note="L -> P (in WSN2; dbSNP:rs59897026)"
FT                   /evidence="ECO:0000269|PubMed:14600690"
FT                   /id="VAR_023924"
FT   VARIANT         112
FT                   /note="N -> S (in WSN2; dbSNP:rs59970018)"
FT                   /evidence="ECO:0000269|PubMed:11379896"
FT                   /id="VAR_016036"
FT   VARIANT         114
FT                   /note="R -> C (in WSN2; unknown pathological significance;
FT                   dbSNP:rs545085703)"
FT                   /evidence="ECO:0000269|PubMed:25606422"
FT                   /id="VAR_086269"
FT   VARIANT         114
FT                   /note="R -> H (in WSN2; unknown pathological significance;
FT                   dbSNP:rs267607388)"
FT                   /evidence="ECO:0000269|PubMed:18616775"
FT                   /id="VAR_086270"
FT   VARIANT         115
FT                   /note="L -> P (in WSN2; dbSNP:rs60906702)"
FT                   /evidence="ECO:0000269|PubMed:10561721"
FT                   /id="VAR_016037"
FT   VARIANT         118
FT                   /note="Y -> D (in WSN2)"
FT                   /evidence="ECO:0000269|PubMed:29476668"
FT                   /id="VAR_086271"
FT   VARIANT         119
FT                   /note="L -> P (in WSN2; dbSNP:rs60440396)"
FT                   /evidence="ECO:0000269|PubMed:7493031"
FT                   /id="VAR_003836"
FT   VARIANT         146
FT                   /note="A -> G (in dbSNP:rs760134)"
FT                   /id="VAR_024488"
FT   VARIANT         187
FT                   /note="A -> V (in dbSNP:rs9891361)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2475110,
FT                   ECO:0000269|PubMed:2477803, ECO:0000269|PubMed:2483837,
FT                   ECO:0000269|PubMed:9714826, ECO:0000269|Ref.6,
FT                   ECO:0007744|PubMed:21269460"
FT                   /id="VAR_060724"
FT   VARIANT         298
FT                   /note="T -> A (in dbSNP:rs4796697)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2475110,
FT                   ECO:0000269|PubMed:2477803, ECO:0000269|PubMed:2483837,
FT                   ECO:0000269|PubMed:9714826, ECO:0000269|Ref.6"
FT                   /id="VAR_059377"
FT   CONFLICT        46
FT                   /note="G -> R (in Ref. 6; BAD96771/BAD96797)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        58
FT                   /note="G -> D (in Ref. 1; CAA32786 and 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   458 AA;  49588 MW;  A51AECFD6195ACB4 CRC64;
     MSLRLQSSSA SYGGGFGGGS CQLGGGRGVS TCSTRFVSGG SAGGYGGGVS CGFGGGAGSG
     FGGGYGGGLG GGYGGGLGGG FGGGFAGGFV DFGACDGGLL TGNEKITMQN LNDRLASYLE
     KVRALEEANA DLEVKIRDWH LKQSPASPER DYSPYYKTIE ELRDKILTAT IENNRVILEI
     DNARLAADDF RLKYENELAL RQSVEADING LRRVLDELTL SKTDLEMQIE SLNEELAYMK
     KNHEEEMKEF SNQVVGQVNV EMDATPGIDL TRVLAEMREQ YEAMAERNRR DAEEWFHTKS
     AELNKEVSTN TAMIQTSKTE ITELRRTLQG LEIELQSQLS MKAGLENTVA ETECRYALQL
     QQIQGLISSI EAQLSELRSE MECQNQEYKM LLDIKTRLEQ EIATYRSLLE GQDAKMIGFP
     SSAGSVSPRS TSVTTTSSAS VTTTSNASGR RTSDVRRP
//
